Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the Liver

Stopped early · Phase 2

Conditions studied: Liver Cancer

In brief

The purpose of this study is to determine the response of liver tumors to radiation therapy using Tomotherapy.

Key facts

Study ID

NCT01030757

Run by

New Mexico Cancer Research Alliance

People needed

2

Starts

2009-06-01

Expected to finish

2013-05-01

Last updated by the study team

2015-07-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologic confirmation of solid primary tumor metastatic to liver
• Age greater than or equal to 18 years old
• Zubrod performance status less than or equal to 1
• Negative pregnancy test for women of child bearing potential
• Informed consent
• Less than or equal to 3 liver metastases
• Each lesion must be less than or equal to 6 cm in maximal diameter
• No prior radiation to lesions being treated
• Patient is not a surgical candidate or refuses surgery
• Absolute neutrophil count ≥ 1800
• Platelets ≥ 100000
• Hemoglobin ≥8.0
• Systemic therapy (chemotherapy) completed at least 2 weeks prior to SBRT
• At time of radiation treatment planning, at least 700 cc of normal liver must receive less than 15 Gy

You may not qualify if…

• Contraindications to radiation
• Pregnant or lactating females who chose to breast feed
• Patients must have recovered from toxicity of prior therapy
• Any co morbid condition that' in the view of the attending physician' renders the patient at high risk from treatment complications
• Patients currently receiving anticoagulation with coumadin or IV heparin
• Liver cirrhosis
• Clinical ascites
• Bilirubin > 3, Albumin < 2.5, liver enzymes 3 times above normal, Creatinine > 1.8

Where it is running

• University of New Mexico Cancer Center — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.